PATENT CLAIM ANALYSIS

Application Number: 15757266
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "557000"]

Abstract:
Certain embodiments are directed to composition and methods related to 23 hydroxy ursolic acid and it use in attenuating the effects to monocyte hypersensitivity or hyper-reactivity

Claim (Index 11):
The method of  claim 1 , wherein the composition is a dietary supplement.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15308427', '15318876', '14650685', '10567543', '13886053']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6643332721969082
- 35 USC 102 Novelty (BERT): 0.5120731460391668
- Combined Prediction Score: 0.6491072595811341
- Mean Citation Score: 191.563408
- Max Citation Score: 203.46341
- Similarity Product: 123.8290482148373

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test